UniProt ID | PRDX6_HUMAN | |
---|---|---|
UniProt AC | P30041 | |
Protein Name | Peroxiredoxin-6 | |
Gene Name | PRDX6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 224 | |
Subcellular Localization | Cytoplasm . Lysosome . Also found in lung secretory organelles (lamellar bodies). | |
Protein Description | Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Can reduce H(2)O(2) and short chain organic, fatty acid, and phospholipid hydroperoxides. Also has phospholipase activity, and can therefore either reduce the oxidized sn-2 fatty acyl grup of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity). These activities are dependent on binding to phospholipids at acidic pH and to oxidized phospholipds at cytosolic pH. Plays a role in cell protection against oxidative stress by detoxifying peroxides and in phospholipid homeostasis.. | |
Protein Sequence | MPGGLLLGDVAPNFEANTTVGRIRFHDFLGDSWGILFSHPRDFTPVCTTELGRAAKLAPEFAKRNVKLIALSIDSVEDHLAWSKDINAYNCEEPTEKLPFPIIDDRNRELAILLGMLDPAEKDEKGMPVTARVVFVFGPDKKLKLSILYPATTGRNFDEILRVVISLQLTAEKRVATPVDWKDGDSVMVLPTIPEEEAKKLFPKGVFTKELPSGKKYLRYTPQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | APNFEANTTVGRIRF CCCCCCCCCEEEEEE | 29.88 | 28857561 | |
32 | Phosphorylation | FHDFLGDSWGILFSH EEHHHCCCEEEEECC | 25.96 | 22673903 | |
44 | Phosphorylation | FSHPRDFTPVCTTEL ECCCCCCCCCEEHHH | 21.07 | 19664994 | |
47 | S-nitrosylation | PRDFTPVCTTELGRA CCCCCCCEEHHHHHH | 4.03 | 25040305 | |
48 | Phosphorylation | RDFTPVCTTELGRAA CCCCCCEEHHHHHHH | 24.44 | 21815630 | |
49 | Phosphorylation | DFTPVCTTELGRAAK CCCCCEEHHHHHHHH | 24.88 | 23403867 | |
56 | Sumoylation | TELGRAAKLAPEFAK HHHHHHHHHCHHHHH | 44.17 | - | |
56 | Ubiquitination | TELGRAAKLAPEFAK HHHHHHHHHCHHHHH | 44.17 | - | |
56 | Sumoylation | TELGRAAKLAPEFAK HHHHHHHHHCHHHHH | 44.17 | - | |
56 | 2-Hydroxyisobutyrylation | TELGRAAKLAPEFAK HHHHHHHHHCHHHHH | 44.17 | - | |
56 | Malonylation | TELGRAAKLAPEFAK HHHHHHHHHCHHHHH | 44.17 | 26320211 | |
56 | Acetylation | TELGRAAKLAPEFAK HHHHHHHHHCHHHHH | 44.17 | 25953088 | |
63 | Ubiquitination | KLAPEFAKRNVKLIA HHCHHHHHCCCEEEE | 50.23 | 21890473 | |
63 | Methylation | KLAPEFAKRNVKLIA HHCHHHHHCCCEEEE | 50.23 | 19608861 | |
63 | Sumoylation | KLAPEFAKRNVKLIA HHCHHHHHCCCEEEE | 50.23 | 19608861 | |
63 | 2-Hydroxyisobutyrylation | KLAPEFAKRNVKLIA HHCHHHHHCCCEEEE | 50.23 | - | |
63 | Acetylation | KLAPEFAKRNVKLIA HHCHHHHHCCCEEEE | 50.23 | 19608861 | |
63 | Sumoylation | KLAPEFAKRNVKLIA HHCHHHHHCCCEEEE | 50.23 | - | |
72 | Phosphorylation | NVKLIALSIDSVEDH CCEEEEEECCCHHHH | 18.48 | 27251275 | |
75 | Phosphorylation | LIALSIDSVEDHLAW EEEEECCCHHHHHHH | 26.24 | 28348404 | |
83 | Phosphorylation | VEDHLAWSKDINAYN HHHHHHHCCCCCCCC | 18.16 | - | |
84 | Ubiquitination | EDHLAWSKDINAYNC HHHHHHCCCCCCCCC | 52.50 | - | |
84 | Acetylation | EDHLAWSKDINAYNC HHHHHHCCCCCCCCC | 52.50 | 26051181 | |
89 | Phosphorylation | WSKDINAYNCEEPTE HCCCCCCCCCCCCCC | 18.83 | 21945579 | |
91 | S-nitrosocysteine | KDINAYNCEEPTEKL CCCCCCCCCCCCCCC | 4.00 | - | |
91 | S-nitrosylation | KDINAYNCEEPTEKL CCCCCCCCCCCCCCC | 4.00 | 19483679 | |
91 | Glutathionylation | KDINAYNCEEPTEKL CCCCCCCCCCCCCCC | 4.00 | 22555962 | |
95 | Phosphorylation | AYNCEEPTEKLPFPI CCCCCCCCCCCCCCE | 49.37 | 21945579 | |
97 | Acetylation | NCEEPTEKLPFPIID CCCCCCCCCCCCEEC | 65.03 | 26051181 | |
97 | Ubiquitination | NCEEPTEKLPFPIID CCCCCCCCCCCCEEC | 65.03 | - | |
97 | 2-Hydroxyisobutyrylation | NCEEPTEKLPFPIID CCCCCCCCCCCCEEC | 65.03 | - | |
106 | Methylation | PFPIIDDRNRELAIL CCCEECCCCHHHHHH | 40.12 | 115488765 | |
108 | Methylation | PIIDDRNRELAILLG CEECCCCHHHHHHHC | 41.00 | 115488757 | |
122 | Acetylation | GMLDPAEKDEKGMPV CCCCHHHCCCCCCCC | 73.60 | 26051181 | |
122 | Sumoylation | GMLDPAEKDEKGMPV CCCCHHHCCCCCCCC | 73.60 | - | |
122 | Ubiquitination | GMLDPAEKDEKGMPV CCCCHHHCCCCCCCC | 73.60 | - | |
125 | Sumoylation | DPAEKDEKGMPVTAR CHHHCCCCCCCCEEE | 71.31 | - | |
125 | Ubiquitination | DPAEKDEKGMPVTAR CHHHCCCCCCCCEEE | 71.31 | 21906983 | |
125 | Acetylation | DPAEKDEKGMPVTAR CHHHCCCCCCCCEEE | 71.31 | 26051181 | |
125 | Sumoylation | DPAEKDEKGMPVTAR CHHHCCCCCCCCEEE | 71.31 | - | |
141 | Ubiquitination | VFVFGPDKKLKLSIL EEEECCCCCEEEEEE | 64.24 | - | |
141 | Acetylation | VFVFGPDKKLKLSIL EEEECCCCCEEEEEE | 64.24 | 25953088 | |
142 | Acetylation | FVFGPDKKLKLSILY EEECCCCCEEEEEEE | 59.23 | 24887509 | |
142 | Sumoylation | FVFGPDKKLKLSILY EEECCCCCEEEEEEE | 59.23 | - | |
144 | 2-Hydroxyisobutyrylation | FGPDKKLKLSILYPA ECCCCCEEEEEEEEC | 49.41 | - | |
144 | Acetylation | FGPDKKLKLSILYPA ECCCCCEEEEEEEEC | 49.41 | 25953088 | |
146 | Phosphorylation | PDKKLKLSILYPATT CCCCEEEEEEEECCC | 14.68 | 20068231 | |
149 | Phosphorylation | KLKLSILYPATTGRN CEEEEEEEECCCCCC | 6.80 | 28152594 | |
152 | Phosphorylation | LSILYPATTGRNFDE EEEEEECCCCCCHHH | 25.86 | 28152594 | |
153 | Phosphorylation | SILYPATTGRNFDEI EEEEECCCCCCHHHH | 35.93 | 28152594 | |
155 | Methylation | LYPATTGRNFDEILR EEECCCCCCHHHHHH | 38.25 | 115488773 | |
166 | Phosphorylation | EILRVVISLQLTAEK HHHHHHHHHEEECCC | 9.84 | 20068231 | |
170 | Phosphorylation | VVISLQLTAEKRVAT HHHHHEEECCCCCCC | 21.58 | 21406692 | |
177 | Phosphorylation | TAEKRVATPVDWKDG ECCCCCCCCCCCCCC | 22.46 | 19664994 | |
182 | 2-Hydroxyisobutyrylation | VATPVDWKDGDSVMV CCCCCCCCCCCEEEE | 47.58 | - | |
182 | Sumoylation | VATPVDWKDGDSVMV CCCCCCCCCCCEEEE | 47.58 | - | |
182 | Methylation | VATPVDWKDGDSVMV CCCCCCCCCCCEEEE | 47.58 | 156701 | |
182 | Acetylation | VATPVDWKDGDSVMV CCCCCCCCCCCEEEE | 47.58 | 26051181 | |
182 | Sumoylation | VATPVDWKDGDSVMV CCCCCCCCCCCEEEE | 47.58 | - | |
182 | Ubiquitination | VATPVDWKDGDSVMV CCCCCCCCCCCEEEE | 47.58 | 21906983 | |
186 | Phosphorylation | VDWKDGDSVMVLPTI CCCCCCCEEEEECCC | 20.03 | 21712546 | |
188 | Sulfoxidation | WKDGDSVMVLPTIPE CCCCCEEEEECCCCH | 2.72 | 21406390 | |
192 | Phosphorylation | DSVMVLPTIPEEEAK CEEEEECCCCHHHHH | 45.03 | 20068231 | |
199 | Ubiquitination | TIPEEEAKKLFPKGV CCCHHHHHHHCCCCC | 53.97 | 21906983 | |
199 | Sumoylation | TIPEEEAKKLFPKGV CCCHHHHHHHCCCCC | 53.97 | - | |
199 | Acetylation | TIPEEEAKKLFPKGV CCCHHHHHHHCCCCC | 53.97 | 26051181 | |
199 | Sumoylation | TIPEEEAKKLFPKGV CCCHHHHHHHCCCCC | 53.97 | - | |
200 | Ubiquitination | IPEEEAKKLFPKGVF CCHHHHHHHCCCCCE | 63.51 | - | |
204 | Sumoylation | EAKKLFPKGVFTKEL HHHHHCCCCCEECCC | 61.44 | - | |
204 | Ubiquitination | EAKKLFPKGVFTKEL HHHHHCCCCCEECCC | 61.44 | - | |
204 | Sumoylation | EAKKLFPKGVFTKEL HHHHHCCCCCEECCC | 61.44 | - | |
204 | Acetylation | EAKKLFPKGVFTKEL HHHHHCCCCCEECCC | 61.44 | 26051181 | |
209 | Acetylation | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | 19608861 | |
209 | Succinylation | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | - | |
209 | Malonylation | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | 26320211 | |
209 | 2-Hydroxyisobutyrylation | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | - | |
209 | Succinylation | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | - | |
209 | Ubiquitination | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | 21890473 | |
209 | Sumoylation | FPKGVFTKELPSGKK CCCCCEECCCCCCCC | 45.87 | 19608861 | |
213 | Phosphorylation | VFTKELPSGKKYLRY CEECCCCCCCCEEEE | 75.71 | 24719451 | |
215 | 2-Hydroxyisobutyrylation | TKELPSGKKYLRYTP ECCCCCCCCEEEECC | 42.45 | - | |
215 | Acetylation | TKELPSGKKYLRYTP ECCCCCCCCEEEECC | 42.45 | 21339330 | |
216 | Acetylation | KELPSGKKYLRYTPQ CCCCCCCCEEEECCC | 53.71 | 21339330 | |
217 | Phosphorylation | ELPSGKKYLRYTPQP CCCCCCCEEEECCCC | 10.41 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
177 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
177 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
177 | T | Phosphorylation | Kinase | MAPK | - | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRDX6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63 AND LYS-209, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-44, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-89, AND MASSSPECTROMETRY. |